Advanced search
Publication Cover
Leukemia & Lymphoma Volume 5, 1991 - Issue sup1
Submit an article Journal homepage
14
Views
6
CrossRef citations to date
0
Altmetric
Original Article

Current Status of U.S. Clinical Trials in Chronic Lymphocytic Leukemia

Bruce D. Cheson Cancer Therapy Evaluation Program, Division of Cancer Treatment, National Cancer Institute, Bethesda. MD, and the Emmes Corporation, Potomac MD, USA
,
Don A. Vena Cancer Therapy Evaluation Program, Division of Cancer Treatment, National Cancer Institute, Bethesda. MD, and the Emmes Corporation, Potomac MD, USA
,
J. Mel Sorensen Cancer Therapy Evaluation Program, Division of Cancer Treatment, National Cancer Institute, Bethesda. MD, and the Emmes Corporation, Potomac MD, USA
&
Alfred Fallavollita Cancer Therapy Evaluation Program, Division of Cancer Treatment, National Cancer Institute, Bethesda. MD, and the Emmes Corporation, Potomac MD, USA
Pages 119-122 | Published online: 01 Jul 2009

References

  • Grever M. R., Leiby J. M., Kraut E. H. Low-dose deoxycoformycin in lymphoid malignancy. J. Clin. Oncol. 1985; 3: 1196–1201
  • Keating M. J. Fludarabine phosphate in the treatment of chronic lymphocytic leukemia. Sem. Oncol. 1990; 17: 49–62, Suppl. 8
  • Piro L. D., Carrera C. J., Beutler E. 2-Chlorodeoxyadenosine: an effective new agent for the treatment of chronic lymphocytic leukemia. Blood 1988; 72: 1069–1073
  • Rai K. R. A critical analysis of staging in CLL. Chronic Lymphocytic Leukemia: Recent Progress and Future Direction, R. P. Gale, K. R. Rai. Alan R. Liss, Inc., New York 1987; 253–264
  • Cheson B. D., Bennett J. M., Rai K. R. Guidelines for clinical protocols for chronic lymphocytic leukemia: Recommendations of the National Cancer Institute-sponsored Working Group. Amer. J. Hematol. 1988; 29: 152–163
  • Elias L., Stock-Novak D., Grever M. A phase I trial of combination fludarabine and chlorambucil in chronic lymphocytic leukemia. Proc. ASCO 1991; 10: 221, (abstr. 745).
  • Gandhi V., Nowak B., Keating M. J. Modulation of arabinosyl-2-fluoroadenine in lymphocytes from patients with chronic lymphocytic leukemia: implications for combination therapy. Blood 1989; 74: 2070–2075
  • Lundberg J. H., Chitambar C. R. Interaction of gallium nitrate with fludarabine and iron chelators. Effects on the proliferation of human leukemic HL-60 cells. Cancer Res. 1990; 50: 6466–6470
  • Malspeis L., Staubus A. E., Lyon M. E. Oral bioavailability of 2-F-ara-A from fludarabine capsules in dogs. Proc. AACR 1989; 30: 534, (abstr. 2124).
  • Tew K. D., Bomer A. M., Hoffman S. J. Ethacrynic acid and piriprost as enhancers of cytotoxicity in drug resistant and sensitive cell lines. Cancer Res. 1988; 48: 3622–3625
  • Silber R., Potmesil M., Bank B. B. Studies on drug resistance in chronic lymphocytic leukemia. Adv. Enz. Reg. 1989; 26: 267–276

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.